exemestane
PolandDrugs containing this active substance
-
Astexana is used to treat early-stage hormone-dependent breast cancer in postmenopausal women (after completion of 2-3 years of tamoxifen treatment) and to treat advanced-stage breast cancer in postmenopausal women who have not responded to other hormonal treatments.
Form: tablets, film-coated
Active substance Dosage exemestane 25 mg ATC: L02BG06
Manufacturer: EirGen Pharma Limited Vipharm S.A.
-
The medicine is used in the treatment of early-stage hormone-dependent breast cancer in postmenopausal women (who have completed 2-3 years of tamoxifen treatment) and in the treatment of advanced stages of this cancer in postmenopausal women for whom other hormonal therapies have not been effective.
Form: tablets, film-coated
Active substance Dosage exemestane 25 mg ATC: L02BG06
Manufacturer: Krka, d.d., Novo mesto
-
It is used for the treatment of early hormone-dependent breast cancer in postmenopausal women (after 2-3 years of treatment with tamoxifen) and for the treatment of advanced breast cancer in postmenopausal women whose disease has progressed despite the use of other hormonal therapies.
Form: tablets, film-coated
Active substance Dosage exemestane 25 mg ATC: L02BG06
Manufacturer: HASCO-LEK S.A. Pharmaceutical Production Enterprise
-
It is used in the treatment of early or advanced hormone-dependent breast cancer in postmenopausal women.
Form: tablets, coated
Active substance Dosage exemestane 25 mg ATC: L02BG06
Manufacturer: Symphar Sp. z o.o.
-
The medicine is used to treat early or advanced hormone-dependent breast cancer in postmenopausal women.
Form: tablets, film-coated
Active substance Dosage exemestane 25 mg ATC: L02BG06
Manufacturer: Remedica Ltd